Antibiotic for skin condition granted Priority Review by FDA
The US FDA have granted the NDA for iclaprim, an antibiotic for a skin condition, Priority Review, with a decision date set for February 2019...
List view / Grid view
News
Common painkiller linked to an increased risk of heart problems
Researchers have identified a widely used pain killer to be linked to an increased risk of heart attack and ischemic stroke...
NHS announces groundbreaking personalised child cancer treatment
The NHS has announced a groundbreaking new treatment, CAR-T, for children with leukaemia...
Gene therapy receives Champalimaud Vision Award
The Champalimaud Vision Award has been awarded to research teams for the development of a gene therapy...
Improving drug safety in East Africa is aim of new project
A new project led by the Karolinska Institutet in Sweden aims to improve the standards of drug safety in East Africa...
Europe ‘needs uniform policy’ to help generic pharmaceuticals market grow: report
A Europe-wide policy covering the generic pharmaceuticals market would significantly boost growth in the sector, reveals a new report from Frost & Sullivan...
FDA piloting innovative clinical trial designs
The US FDA is looking to begin a new phase of innovative clinical trial designs...
Tetrahertz spectroscopy could be used to monitor single molecules
Researchers have identified a method of using Tetrahertz spectroscopy to monitor the movement of single molecules...
Multiple sclerosis drug slows brain shrinkage
In a recent clinical study, ibudilast slowed brain shrinkage better than a placebo in the brains of patients with multiple sclerosis...
Unnecessary heart procedures avoided thanks to non-invasive test
This is the first study to show the clinical benefit of FFRCT in patients with moderate stenosis, said Dr Bjarne Linde Norgaard of Aarhus University Hospital...
New programme increases use of HIV medication in injection-drug users
Researchers have outlined a simple method to increase the number of injection-drug taking individuals with HIV to adhere to their medication...
Blood pressure drug slows aortic dilatation in Marfan syndrome
“Our finding of reduced aortic dilatation with irbesartan, over and above standard medical therapy, suggests an important clinical effect that may prevent complications and ultimately delay or obviate the need for surgical intervention in patients with Marfan syndrome,” said Dr Mullen.
Seizures could be stopped and prevented with implanted electronic device
Researchers have developed an electronic device which could help to detect, prevent and stop seizures from occurring in epileptic patients...
Oral anticoagulants and antiplatelets linked to poor outcome in atrial fibrillation
The results challenged the use of combined oral anticoagulant and antiplatelet therapy in patients with atrial fibrillation, especially those without an indication for antiplatelet therapy.
FDA approves first drug for neurotrophic keratitis
The FDA has approved the first treatment for neurotrophic keratitis, which completely healed the rare disease in 70 percent of cases.
